Roy Proujansky serves as Executive at INNOVATE BIOPHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Roy Proujansky has executed 2 insider transactions totaling $5.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 24, 2019 involved purchasing 1,000 shares valued at $1.3K.
Roy Proujansky currently holds 2,400 shares of INNOVATE BIOPHARMACEUTICALS, INC. (INNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roy Proujansky has been a net buyer of INNT stock. They have purchased $5.0K and sold $0 worth of shares.
Roy Proujansky's most recent insider trade was on May 24, 2019, when they purchased 1,000 shares at $1.28 per share.
Get notified when new Form 4 filings are submitted
| $2.63 |
| Discretionary |